Last reviewed · How we verify
NCT06848660: SOFT
Study on Orthosis in Cervical Spine Fracture Treatment
NA trial testing A rigid cervical collar in Cervical Spine Fractures in 616 participants. Currently enrolling.
1 June 2030
Quick facts
| Lead sponsor | Uppsala University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 616 |
| Start date | 1 November 2025 |
| Primary completion | 1 June 2030 |
| Estimated completion | 30 December 2031 |
| Sites | 6 locations across Sweden |
Drugs / interventions tested
- A rigid cervical collar
Conditions studied
- Cervical Spine Fractures — all drugs for Cervical Spine Fractures →
- Cervical Spine Injury — all drugs for Cervical Spine Injury →
- Rigid Collar — all drugs for Rigid Collar →
Sponsor
Uppsala University Hospital
Who can join
18 and older, any sex, with Cervical Spine Fractures or Cervical Spine Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background and Purpose: Neck fractures affect over 1,100 people in Sweden each year, with the majority being frail older adults. Most neck fractures are stable and therefore treated without surgery, typically using a rigid collar. However, the collar only limits neck movement by 40-50% and can cause pressure sores, as well as difficulties with swallowing and breathing. Because of these issues, the latest Swedish national guidelines for pre-hospital and hospital spinal motion restriction have replaced the rigid collar with other methods. This raises the question of whether the rigid collar still has a role in the modern treatment of stable neck fractures. The aim of this study is to determine whether treatment with or without a rigid collar leads to equally good healing outcomes. Method: All adults diagnosed with a stable neck fracture deemed suitable for non-surgical treatment will be included in the study at the time of registration in the Swedish Fracture Register (SFR). Participating hospitals will be randomly assigned (1:1) to either use no collar at all or a rigid collar for 12 weeks. After an initial period of 1.5 years, the hospitals will switch to the opposite treatment group. A total of 616 participants are expected to be included within 3 years. At the one-year follow-up, investigators will evaluate how many participants in each treatment group that required a switch to surgical stabilization due to treatment failure. Secondary outcomes will include quality of life, neck pain, and the need for assistive devices in relation to disability and complications in both groups. Summary: Non-surgical treatment rarely fails, and the need to switch from non-surgical treatment to surgery is very uncommon. The rigid collar is often prescribed out of habit, without much consideration for its potential negative effects. If this study shows that the rigid collar is unnecessary for treating stable neck fractures, frail older adults-who often struggle with collar-related discomfort, malnutrition, and pressure sores-could avoid unnecessary suffering.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06848660
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Uppsala University Hospital trials
Trials by the same sponsor.
- NCT06610214 — IMPACT-care (Improved Medication Communication and Patient Involvement at Care Transitions) · NA · completed
- NCT06621381 — Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder · NA · recruiting
- NCT06372444 — Mechanisms of Acute Kidney Injury in Severe Infections · recruiting
- NCT06261411 — Lung Ultrasound as Alternative to Radiography in Thoracic Surgery · NA · active not recruiting
- NCT05814887 — Reduction of Mechanical IV Complication Using a New Medical Device · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06848660 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uppsala University Hospital
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06848660.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing